ORCHESTRA BIOMED HOLDINGS IN (OBIO)
US68572M1062 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -780K -113.68% | 3.53M 552.56% | 2.76M -21.81% | 3.384M 22.61% | 3.947M 16.64% | 3.953M 0.15% | 4.103M 3.79% | 27.812M 577.85% | 76.594M 175.40% | 156.57M 104.42% | 163.2M 4.23% | |
| EBITDA YoY % growth | -21.62M -16.17% | -32.44M -50.05% | -51.219M -57.89% | -65.28M -27.45% | -77.52M -18.75% | -66.3M 14.47% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -21.8M -16.27% | -32.66M -49.82% | -51.506M -57.70% | -65.695M -27.55% | -77.715M -18.30% | -66.986M 13.81% | -70.568M -5.35% | -46.09M 34.69% | -8.351M 81.88% | 46.832M 660.81% | N/A | |
| Operating Margin | 2,794.87% | -925.21% | -1,866.16% | -1,941.34% | -1,968.97% | -1,694.56% | -1,719.90% | -165.72% | -10.90% | 29.91% | N/A | |
| EPS YoY % growth | N/A | N/A | -1.50 84.66% | -1.69 -12.80% | -1.99 -17.81% | -1.75 12.24% | -1.74 0.29% | -1.01 42.11% | -0.07 92.93% | 1.17 1,742.86% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.44 -17.93% | -0.47 -24.95% | -0.50 -12.20% | -0.52 -25.82% | -0.51 -17.52% |
| Revenue Q2Q % growth | 845.988K 222.90% | 848.13K 36.80% | 912.135K 17.24% | 976.905K -1.02% | 909.585K 7.52% |
| EBITDA Q2Q % growth | -17.34M -42.20% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.278M -38.43% | -18.942M -31.33% | -20.507M -21.64% | -21.147M -29.40% | -21.798M -26.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.41 -7.89% | -0.44 | 0.03 | 6.52% |
| Q2 2024 Q2Q % growth | -0.45 -28.57% | -0.40 | -0.05 | -12.33% |
| Q1 2024 Q2Q % growth | -0.38 5.00% | -0.41 | 0.03 | 6.39% |
| Q4 2023 Q2Q % growth | -0.37 78.79% | -0.38 | 0.01 | 3.65% |
| Q3 2023 Q2Q % growth | -0.38 | -0.40 | 0.02 | 4.47% |
| Q2 2023 Q2Q % growth | -0.35 | -0.42 | 0.07 | 17.32% |
| Q1 2023 Q2Q % growth | -0.40 | -0.29 | -0.11 | -37.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 987K 135.56% | 725.73K | 261.27K | 36.00% |
| Q2 2024 Q2Q % growth | 778K -14.97% | 870.57K | -92.57K | -10.63% |
| Q1 2024 Q2Q % growth | 620K -46.74% | 955.403K | -335.403K | -35.11% |
| Q4 2023 Q2Q % growth | 262K -76.18% | 1.014M | -752K | -74.16% |
| Q3 2023 Q2Q % growth | 419K -63.88% | 912.9K | -493.9K | -54.10% |
| Q2 2023 Q2Q % growth | 915K 128.75% | 720.12K | 194.88K | 27.06% |
| Q1 2023 Q2Q % growth | 1.164M 33.79% | 693.6K | 470.4K | 67.82% |
| Q4 2022 Q2Q % growth | 1.1M 144.90% | 1.204M | -104K | -8.64% |
| Q3 2022 Q2Q % growth | 1.16M -12.78% | % | ||
| Q2 2022 Q2Q % growth | 400K 140.82% | % | ||
| Q1 2022 Q2Q % growth | 870K -34.09% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -11.55% | 0.1% | 1.11% |
| Revenue | 0% | -20.64% | 9.09% | 13.86% |